Keep Your Clinical Research on Track

DIGITALLY ENABLING YOUR CLINICAL TRIALS KEEPS PATIENTS ENGAGED

With uncertainties introduced by the COVID-19 pandemic, the need for seamless decentralized research models are more important than ever. With the growing need to keep research moving forward, the development of new technologies and systems for sites, patients and sponsors has also grown. Today’s leading platforms emphasize putting minimal burden on the patient, including the evaluation of how the investigational medicinal product (IMP) will be administered or how vitals and endpoints are collected.

As the clinical landscape continues to evolve, PPD® Digital has the resources and powerful partnerships to design and deploy hybrid and decentralized trials in the dermatology space. Our experience has allowed us to respond quickly in an unpredictable time, providing the support and insight needed to address heightened risks and keep trials on track for customers and the many patients who have invested hope in the research.

PPD Digital continues to lead the way for decentralized trial strategies, frequently publishing insights into trends, available solutions, and which options are optimal for ongoing and planned clinical trials. Complete the form to read our latest insights on how decentralized trials are taking form in the dermatology space.

MORE ON ACCELERATING DERMATOLOGY RESEARCH REMOTELY

SOLUTIONS

Telemedicine & Televisits
Remote eConsent
eCOA & ePRO
Direct-To/From- Patient Models
Home Health Care and Nursing
Remote Monitoring